
#169: Multiple Sclerosis in Nepal. Diagnosis, Treatment and Access to Care
Multiple Sclerosis in Nepal is still often overlooked, diagnosed late, and difficult to treat because access to MRI, neurologists, and

Multiple Sclerosis in Nepal is still often overlooked, diagnosed late, and difficult to treat because access to MRI, neurologists, and

In this interview, Dr. Isabel Voigt explains how the MS360° approach could help transform multiple sclerosis care. By combining digital monitoring, telemedicine, real-world data, and in-person visits, the model aims to detect changes earlier, improve communication, and support more personalized MS treatment.

CAR-T cell therapy is one of the most promising yet complex developments in multiple sclerosis research. In this in-depth interview, Professor Barbara Willekens explains how the therapy works, who might benefit, and what we know so far about its risks and potential. A scientifically grounded look at a treatment that could reshape the future of MS care.

Pain is one of the most challenging symptoms of multiple sclerosis. In this interview, Dr. Camelia Ionescu explains the mechanisms behind MS-related pain and how multimodal treatment approaches can help. Get practical tips and insights to improve quality of life despite chronic pain.

This episode explores progressive MS (PMS), including PPMS and SPMS, with neurologist Dr. Thomas Knoll. Learn about disease mechanisms, treatment limits, and how to actively maintain quality of life.

How is multiple sclerosis managed in Saudi Arabia today? In this episode, neurologist Dr. Yasser Alamri shares insights on treatment access, research, and patient support. Discover how awareness and care are evolving—and why early treatment makes a difference.

Shared decision making in multiple sclerosis helps patients and doctors choose the best treatment together. In this interview, Dr. Jens Ulrich Rüffer explains how patient empowerment improves outcomes and why this approach is the future of MS care.

Optical coherence tomography (OCT) is a quick and non-invasive eye scan that allows researchers to examine the retina in great detail. Because the retina is part of the central nervous system, OCT may help monitor neurodegeneration and disease activity in multiple sclerosis.
In this interview, neurologist Dr. Joachim Havla explains how OCT works, what retinal thinning may reveal about MS progression, and why it is important to distinguish optic neuritis in MS, NMOSD and MOGAD.
This article is the English adaptation of a German MS-Perspektive podcast episode.
I show you how to make the best of your life with MS from family to career to hobbies. Thanks to science and research, a lot is possible nowadays.
Then get 11 impulses for a positive course as a gift and receive important information about the disease.
Sign up for the newsletter now and get 11 tips on how you can positively influence your progress.
Wait a moment!
Sign up for the newsletter now and get 11 tips on how you can positively influence your progress.
You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information